Home › Funds › LBP AM SA › BNTX
LBP AM SA position in BNTX
BIONTECH SE · Health Care
LBP AM SA reported holding 329,270 shares of BNTX (BIONTECH SE) in its Q3 2026 13F filing — a position valued at US$32.4M, representing 0.29% of its reported portfolio and ranking #47 among its reported holdings. LBP AM SA has disclosed BNTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How LBP AM SA's BNTX position evolved
LBP AM SA first disclosed a stake in BNTX in Q3 2024 at 247,833 shares (US$29.4M). The position peaked in Q2 2026 at 388,498 shares, worth US$36.1M. Across 9 filings, LBP AM SA increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 329,270 shares valued at US$32.4M — a reduction of -59,228 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 247.83K | $29.44M | New |
| Q4 2024 | 252.92K | $28.82M | Add |
| Q1 2025 | 305.22K | $27.79M | Add |
| Q2 2025 | 305.47K | $32.52M | Hold |
| Q3 2025 | 353.33K | $34.85M | Add |
| Q4 2025 | 368.58K | $35.09M | Add |
| Q1 2026 | 385.11K | $34.23M | Add |
| Q2 2026 | 388.50K | $36.15M | Add |
| Q3 2026 | 329.27K | $32.37M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BNTX and 13F data
BNTX (BIONTECH SE) is a Health Care company. 28 other funds we track also report a position in BNTX — the largest reported positions include Logos Global Management LP (US$94.4M), Davern Capital Partners, LP (US$67.1M), GSK plc (US$65.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNTX
- Logos Global Management LP 1.01M sh · $94.45M · Q2 2026
- Davern Capital Partners, LP 682.15K sh · $67.06M · Q3 2026
- GSK plc 668.53K sh · $65.72M · Q3 2026
- Long Focus Capital Management, LLC 624.00K sh · $58.06M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K sh · $43.73M · Q2 2026
More on LBP AM SA
FAQ
How long has LBP AM SA held BNTX?
LBP AM SA has disclosed BNTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is LBP AM SA's current position in BNTX?
As of Q3 2026, LBP AM SA holds 329.27K shares of BNTX (BIONTECH SE), valued at $32.37M, representing 0.29% of its reported portfolio and ranking #47.
Has LBP AM SA been buying or selling BNTX?
In the latest 13F filing (Q3 2026), LBP AM SA reduced its position in BNTX. The position peaked in Q2 2026 at 388.50K shares.
Which other funds hold BNTX?
Other major institutional holders of BNTX include Logos Global Management LP, Davern Capital Partners, LP, GSK plc, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.